Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
ImmuneOnco Biopharmaceuticals (Shanghai) (IOB HK)
Watchlist
8
Analysis
Health Care
•
China
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
ImmuneOnco Biopharmaceuticals (Shanghai)
•
15 Aug 2023 08:55
Pre-IPO ImmuneOnco Biopharmaceuticals (PHIP Updates) - Slow Development Progress and Gloomy Outlook
ImmuneOnco's business model is self-development, leading to slow progress. Druggability/safety profile of CD47-targeted molecules are the biggest...
Xinyao (Criss) Wang
Follow
245 Views
Share
bearish
•
ImmuneOnco Biopharmaceuticals (Shanghai)
•
16 May 2023 14:19
ImmuneOnco (宜明昂科) Pre-IPO: Clinical Numbers Are yet to Be Convincing
We look at ImmuneOnco, a biotech company seeking a listing in Hong Kong. The company is focused on CD47 products. Given the clinical data presented...
Ke Yan, CFA, FRM
Follow
262 Views
Share
bullish
•
ImmuneOnco Biopharmaceuticals (Shanghai)
•
03 Aug 2022 23:28
ImmuneOnco Biopharmaceuticals (IOB HK) Pre-IPO: A Potentially Differentiated Oncology Portfolio
The company intends to list its shares on HK stock exchange. Investors, with high-risk appetite can consider this IPO for long-term investment due...
Tina Banerjee
Follow
319 Views
Share
Previous
1
2
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x